Accrol Group Holdings PLC Board and Board Committee Changes (5468F)

TIDMACRL

RNS Number : 5468F

Accrol Group Holdings PLC

29 October 2018

For immediate release on 29 October 2018

Accrol Group Holdings plc

("Accrol Group" or the "Company")

AIM: ACRL

Board and Board Committee Changes

Accrol Group, the UK's leading independent tissue converter, announces that Joanne Lake has given notice that she wishes to step down from the Board and leave the Company with effect from today to pursue other opportunities, alongside her existing portfolio of chairman and non-executive director responsibilities.

Simon Allport, who joined the Board on 10 October 2018, replaces Joanne as Chairman of the Audit Committee with immediate effect.

Following Joanne's departure, the Directors will continue discussions with other potential non-executive directors to further strengthen the Board in due course.

Dan Wright, Executive Chairman of Accrol Group, said: "I would like to thank Joanne for her contribution to the Board, particularly during the two fundraisings that were undertaken to secure the future of the business. On behalf of the Board, I wish her all the best for the future."

 
For further information, please contact: 
 
Accrol Group Holdings plc 
Dan Wright, Executive Chairman              Tel: [phone] 
Gareth Jenkins, Chief Executive Officer 
Steve Townsley, Chief Financial Officer 
 
Zeus Capital Limited (Nominated Adviser 
 & Broker) 
Dan Bate / Andrew Jones                     Tel: [phone] 
Dominic King / John Goold                   Tel: [phone] 
 
Belvedere Communications Limited 
Cat Valentine ([e-mail])  Tel: [phone] 
Llew Angus ([e-mail])         Tel: [phone] 
 

Notes to Editors

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK.

Accrol operates from three sites:

   --      A manufacturing, storage and distribution facility in Blackburn; 
   --      A facial tissue plant, also in Blackburn; and 
   --      A manufacturing, storage and distribution facility in Leyland. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

BOAUKUARWOARUAA

(END) Dow Jones Newswires

October 29, 2018 07:24 ET (11:24 GMT)